Primary Care / Primary Health Care / Public Health / Quality Control / Spain / Pharmaceutical industry / Humans / Cost effectiveness / National Health Service / Case Management / Government Agencies / Self medication / Patient Care / Cost Benefit Analysis / Drug Costs / Polypharmacy / Low Risk / Health Priorities / Drug Utilization / Electronic Medical Record / Pharmaceutical industry / Humans / Cost effectiveness / National Health Service / Case Management / Government Agencies / Self medication / Patient Care / Cost Benefit Analysis / Drug Costs / Polypharmacy / Low Risk / Health Priorities / Drug Utilization / Electronic Medical Record
Primary Care / Primary Health Care / Public Health / Quality Control / Spain / Pharmaceutical industry / Humans / Cost effectiveness / National Health Service / Case Management / Government Agencies / Self medication / Patient Care / Cost Benefit Analysis / Drug Costs / Polypharmacy / Low Risk / Health Priorities / Drug Utilization / Electronic Medical Record / Pharmaceutical industry / Humans / Cost effectiveness / National Health Service / Case Management / Government Agencies / Self medication / Patient Care / Cost Benefit Analysis / Drug Costs / Polypharmacy / Low Risk / Health Priorities / Drug Utilization / Electronic Medical Record
Primary Health Care / Quality Control / Spain / Humans / Case Management / Government Agencies / Self medication / Cost Benefit Analysis / Drug Costs / Polypharmacy / Health Priorities / Drug Utilization / Government Agencies / Self medication / Cost Benefit Analysis / Drug Costs / Polypharmacy / Health Priorities / Drug Utilization
Risk Management / Spain / Medical errors / Software / New Technologies / Humans / United States / Pneumonia / Lung Diseases / Clinical Sciences / Drug Costs / Polypharmacy / Public Art Hospitals / Humans / United States / Pneumonia / Lung Diseases / Clinical Sciences / Drug Costs / Polypharmacy / Public Art Hospitals